Keywords: connetics, sees, 4th-qtr, product, revenues, rise, corp
Connetics sees 4th-qtr product revenues rise 50%
Article | 03 February 2003
Connetics Corp, a specialty US firm focused exclusively on thedevelopment and commercialization of medicinal dermatology products, says that fourth-quarter 2002 product ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
